Middle East and Africa Stroke Diagnostics Market, By Severity (Moderate, Severe, Mild), Type (Computed Tomography (CT Scan), Computed Tomography Angiography (CTA), Magnetic Resonance Imaging (MRI), Magnetic Resonance Angiography (MRA), Transcranial Doppler Ultrasound, Video Head Impulse Test (VHIT), Others), Application (Ischemic Stroke, Hemorrhagic Stroke, Transient Ischemic Attacks (TIAS)), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Healthcare), Distribution Channel ( Direct Tender, Third Party Distributors, Others), Stage (Pre Operative, Peri Operative, Post Operative), Country (Saudi Arabia, South Africa, and Rest of the Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Middle East and Africa Stroke Diagnostics Market
The Middle East and Africa stroke diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.7% in the forecast period of 2021 to 2028 and is expected to reach USD 222.27 million by 2028. Rising disposable incomes and an increase in new product development are the major drivers which are expected to propel the demand of the market in the forecast period. However, an increase in restriction during a pandemic may restrain the market.
A stroke occurs when the supply of blood to the brain is decreased or blocked completely, which prevents the brain tissue from getting oxygen and nutrients. There are various types of diagnostics devices that are being used to detect stroke and its early symptoms, for instance, computed tomography (CT SCAN), computed tomography angiography (CTA), magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), transcranial Doppler ultrasound and others.
The increasing incidence of stroke and cardiovascular and neurological disease has increased the demand for stroke diagnostics in developing countries. Also, the rise in healthcare expenditure is propelling market growth. On the other hand, the high cost of diagnosis may hinder market growth. The presence of market players and new product launches is providing an opportunity. However, the lack of skilled professionals may challenge the market.
The stroke diagnostics market report provides details of market share, new developments, the impact of domestic and localized market players, analysis of opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.
Middle East And Africa Stroke Diagnostics Market Scope And Market Size
The Middle East and Africa stroke diagnostics market is segmented on the basis of severity, type, application, end user, distribution channel, and stage.
- On the basis of severity, the Middle East and Africa stroke diagnostics market is segmented into moderate, severe, and mild. In 2021, the moderate segment is expected to dominate the market, with an increase in the increasing awareness regarding stroke and early diagnosis.
- On the basis of type, the Middle East and Africa stroke diagnostics market is segmented into computed tomography (CT Scan), computed tomography angiography (CTA), magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), transcranial Doppler ultrasound, video head impulse test (VHIT), other. In 2021, the computed tomography (CT scan) segment is expected to dominate the market with the increasing government initiatives to provide a better diagnosis.
- On the basis of application, the Middle East and Africa stroke diagnostics market is segmented into an ischemic stroke, hemorrhagic stroke, and transient ischemic attacks (TIAS). In 2021, ischemic stroke is expected to dominate the market with favorable government regulations regarding diagnostic devices.
- On the basis of end-users, the Middle East and Africa stroke diagnostics market is segmented into hospitals, home healthcare, ambulatory surgical centers, and clinics. In 2021, the hospital segment is expected to dominate the market due to the increasing healthcare expenditure and advancement in hospital facilities.
- On the basis of distribution channel, the Middle East and Africa stroke diagnostics market is segmented into direct tender, third party distributor, and others. In 2021, direct tender is expected to dominate the market due to the direct link of the manufacturer to the customers.
- On the basis of stages, the Middle East and Africa stroke diagnostics market is segmented into pre-operative, peri-operative, and post-operative. In 2021, pre-operative is expected to dominate the market due to the increasing prevalence of heart disease.
Middle East and Africa Stroke Diagnostics Market Country Level Analysis
The Middle East and Africa stroke diagnostics market is analyzed, and market size information is provided on the basis of severity, type, application, end user, distribution channel, and stage.
The countries covered in the stroke diagnostics market report are South Africa, Saudi Arabia, and the rest of the Middle East and Africa.
The Middle East and Africa stroke diagnostics market is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of the increasing number of stroke diagnostics manufacturers and R&D activities. South Africa is expected to dominate the Middle East and Africa stroke diagnostics market due to an increase in the incidence of disease of cardiovascular diseases in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of the Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Rising New Product Development Are Boosting the Market Growth Of Stroke Diagnostics
The stroke diagnostics market also provides you with detailed market analysis for every country's growth in the stroke diagnostics industry with stroke diagnostics drugs sales, the impact of advancement in the Stroke diagnostics technology, and changes in regulatory scenarios with their support for the Stroke diagnostics market. The data is available for the historic period 2011 to 2019.
Competitive Landscape and Stroke diagnostics Market Share Analysis
Stroke diagnostics market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus related to the stroke diagnostics market.
The major companies which are dealing in the Middle East and Africa stroke diagnostics market are Siemens, Koninklijke Philips N.V., General Electric Company, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., FUJIFILM Holdings Corporation, Analogic Corporation, Aspect Imaging Ltd, Carestream Health, ESAOTE SPA, Hologic, Inc., IMRIS, Deerfield Imaging Inc., MEDTRON AG, Neusoft Corporation, SAMSUNG, Shenzhen Anke High-Tech CO., Ltd., Shimadzu Corporation, SternMed GmbH, Stryker, among others.
Many product launches and agreements are also initiated by companies worldwide, which also accelerates the stroke diagnostics market.
For instance,
- In May 2021, Shimadzu Corporation announced its joint research agreement with Washington University School of Medicine in St. Louis to apply mass spectrometry technology toward the development of new products. It will enhance the company's R&D activities
- In November 2020, Stryker announced that it had acquired the Wright Medical Group N.V., a medical devices company focused on extremities and biologics across the globe. The acquisition done by the company has increased the product portfolio of the company leading to increased sales and demand for its products in the future
Collaboration, product launch, business expansion, award and recognition, joint ventures, and other strategies by the market player are enhancing the company market in the stroke diagnostics market, which also provides the benefit for the organization to improve their offering for stroke diagnostics.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES MODEL
5 EPIDEMIOLOGY
6 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: REGULATIONS
6.1 REGULATION IN THE U.S.
6.2 REGULATION IN EUROPE
6.3 REGULATION IN CHINA
6.4 REGULATION IN JAPAN
6.5 REGULATION IN SOUTH AFRICA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 TECHNOLOGICAL ADVANCEMENT
7.1.2 INCREASE IN THE INCIDENCE OF STROKE
7.1.3 INCREASE IN THE GERIATRIC POPULATION
7.1.4 INCREASE IN NUMBER OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASES
7.2 RESTRAINTS
7.2.1 HIGH COST OF DIAGNOSIS
7.2.2 INCREASE IN PRODUCT RECALL
7.3 OPPORTUNITIES
7.3.1 RISE IN HEALTHCARE SPENDING
7.3.2 INCREASE IN DIABETIC POPULATION AND OBESITY
7.3.3 INCREASE IN FDA APPROVAL AND PRODUCT LAUNCH
7.3.4 RISE IN AWARENESS REGARDING HEALTH AND STROKE
7.4 CHALLENGES
7.4.1 UNFAVORABLE REIMBURSEMENT SCENARIO
7.4.2 COMPLICATION RELATED TO DIAGNOSTIC DEVICES
8 IMPACT OF COVID-19 ON MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET
8.1 IMPACT ON PRICE
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC INITIATIVES
8.5 CONCLUSION
9 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET, BY SEVERITY
9.1 OVERVIEW
9.2 MODERATE
9.3 SEVERE
9.4 MILD
10 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET, BY TYPE
10.1 OVERVIEW
10.2 COMPUTED TOMOGRAPHY (CT SCAN)
10.3 COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA)
10.4 MAGNETIC RESONANCE IMAGING (MRI)
10.5 MAGNETIC RESONANCE ANGIOGRAPHY (MRA)
10.6 TRANSCRANIAL DOPPLER ULTRASOUND
10.7 VIDEO HEAD IMPULSE TEST (VHIT)
10.8 OTHERS
10.8.1 CAROTID ULTRASOUND
10.8.2 CAROTID ANGIOGRAPHY
10.8.3 ELECTROCARDIOGRAPHY (EKG)
10.8.4 ECHOCARDIOGRAPHY
10.8.5 BLOOD TESTS
10.8.6 NUCLEAR NEUROIMAGING
10.8.7 OTHERS
11 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 ISCHEMIC STROKE
11.2.1 THROMBOTIC STROKES
11.2.2 EMBOLIC STROKES
11.3 HEMORRHAGIC STROKE
11.3.1 INTRACEREBRAL HEMORRHAGE
11.3.2 SUBARACHNOID HEMORRHAGE
11.4 TRANSIENT ISCHEMIC ATTACKS (TIAS)
12 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITAL
12.3 CLINICS
12.4 AMBULATORY SURGICAL CENTERS
12.5 HOME HEALTHCARE
12.6 OTHERS
13 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 THIRD PARTY DISTRIBUTORS
13.4 OTHERS
14 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET, BY STAGE
14.1 OVERVIEW
14.2 PRE OPERATIVE
14.3 PERI OPERATIVE
14.4 POST OPERATIVE
15 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET, BY REGION
15.1 MIDDLE EAST AND AFRICA
15.1.1 SAUDI ARABIA
15.1.2 SOUTH AFRICA
15.1.3 REST OF MIDDLE EAST AND AFRICA
16 STROKE DIAGNOSTICS MARKET COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 SIEMENS
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 KONINKLIJKE PHILIPS N.V.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 GENERAL ELECTRIC COMPANY
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENTS
18.4 CANON INC
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENTS
18.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.6 ALPINION MEDICAL SYSTEMS CO., LTD
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENTS
18.7 ANALOGIC CORPORATION
18.7.1 COMPANY SNAPSHOT
18.7.2 PRODUCT PORTFOLIO
18.7.3 RECENT DEVELOPMENT
18.8 ASPECT IMAGING LTD
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENT
18.9 BPL MEDICAL TECHNOLOGIES
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENT
18.1 CARESTREAM HEALTH
18.10.1 COMPANY SNAPSHOT
18.10.2 REVENUE ANALYSIS
18.10.3 PRODUCT PORTFOLIO
18.10.4 RECENT DEVELOPMENTS
18.11 ESAOTE SPA
18.11.1 COMPANY SNAPSHOT
18.11.2 PRODUCT PORTFOLIO
18.11.3 RECENT DEVELOPMENTS
18.12 FONAR CORP
18.12.1 COMPANY SNAPSHOT
18.12.2 REVENUE ANALYSIS
18.12.3 PRODUCT PORTFOLIO
18.12.4 RECENT DEVELOPMENT
18.13 FUJIFILM HOLDINGS CORPORATION
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 PRODUCT PORTFOLIO
18.13.4 RECENT DEVELOPMENTS
18.14 HOLOGIC, INC
18.14.1 COMPANY SNAPSHOT
18.14.2 REVENUE ANALYSIS
18.14.3 PRODUCT PORTFOLIO
18.14.4 RECENT DEVELOPMENTS
18.15 IMRIS, DEERFIELD IMAGING INC.
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
18.16 MEDFIELD DIAGNOSTICS AB
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENT
18.17 MEDTRON AG
18.17.1 COMPANY SNAPSHOT
18.17.2 PRODUCT PORTFOLIO
18.17.3 RECENT DEVELOPMENT
18.18 NEUSOFT CORPORATION
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 PRODUCT PORTFOLIO
18.18.4 RECENT DEVELOPMENT
18.19 SAMSUNG
18.19.1 COMPANY SNAPSHOT
18.19.2 REVENUE ANALYSIS
18.19.3 PRODUCT PORTFOLIO
18.19.4 RECENT DEVELOPMENTS
18.2 SHENXHEN ANKE HIGH-TECH CO., LTD.
18.20.1 COMPANY SNAPSHOT
18.20.2 PRODUCT PORTFOLIO
18.20.3 RECENT DEVELOPMENT
18.21 SHIMADZU CORPORATION
18.21.1 COMPANY SNAPSHOT
18.21.2 REVENUE ANALYSIS
18.21.3 PRODUCT PORTFOLIO
18.21.4 RECENT DEVELOPMENTS
18.22 SIUI
18.22.1 COMPANY SNAPSHOT
18.22.2 PRODUCT PORTFOLIO
18.22.3 RECENT DEVELOPMENTS
18.23 STERNMED GMBH
18.23.1 COMPANY SNAPSHOT
18.23.2 PRODUCT PORTFOLIO
18.23.3 RECENT DEVELOPMENT
18.24 STRYKER
18.24.1 COMPANY SNAPSHOT
18.24.2 REVENUE ANALYSIS
18.24.3 PRODUCT PORTFOLIO
18.24.4 RECENT DEVELOPMENTS
18.25 TERASON DIVISION TERATECH CORPORATION
18.25.1 COMPANY SNAPSHOT
18.25.2 PRODUCT PORTFOLIO
18.25.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
List of Table
TABLE 1 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 2 MIDDLE EAST & AFRICA MODERATE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA SEVERE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA MILD IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA COMPUTED TOMOGRAPHY (CT SCAN) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING (MRI) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY (MRA) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA TRANSCRANIAL DOPPLER ULTRASOUND IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA VIDEO HEAD IMPULSE TEST (VHIT) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA ISCHEMIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA HEMORRHAGIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA TRANSIENT ISCHEMIC ATTACKS (TIAS) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA HOSPITAL IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA CLINICS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA HOME HEALTHCARE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA DIRECT TENDER IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA THIRD PARTY DISTRIBUTORS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA PRE OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA PERI OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA POST OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 44 SAUDI ARABIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 45 SAUDI ARABIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 46 SAUDI ARABIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 47 SAUDI ARABIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 48 SAUDI ARABIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 49 SAUDI ARABIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 50 SAUDI ARABIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 51 SAUDI ARABIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 52 SAUDI ARABIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 53 SOUTH AFRICA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 54 SOUTH AFRICA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 55 SOUTH AFRICA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 SOUTH AFRICA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 SOUTH AFRICA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 58 SOUTH AFRICA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 59 SOUTH AFRICA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 SOUTH AFRICA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 SOUTH AFRICA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 62 REST OF MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
List of Figure
FIGURE 1 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN DEMAND FOR STROKE DIAGNOSTISIS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 MODERATE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET IN 2021 & 2028
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET
FIGURE 15 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY SEVERITY, 2020
FIGURE 16 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY SEVERITY, 2020-2028 (USD MILLION)
FIGURE 17 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY SEVERITY, CAGR (2021-2028)
FIGURE 18 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY SEVERITY, LIFELINE CURVE
FIGURE 19 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY TYPE, 2020
FIGURE 20 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY TYPE, 2020-2028 (USD MILLION)
FIGURE 21 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 22 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 23 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY APPLICATION, 2020
FIGURE 24 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 25 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 26 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 27 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY END USER, 2020
FIGURE 28 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY END USER, 2020-2028 (USD MILLION)
FIGURE 29 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY END USER, CAGR (2021-2028)
FIGURE 30 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE
FIGURE 31 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 32 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
FIGURE 33 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 34 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 35 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY STAGE, 2020
FIGURE 36 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY STAGE, 2020-2028 (USD MILLION)
FIGURE 37 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY STAGE, CAGR (2021-2028)
FIGURE 38 MIDDLE EAST & AFRICA STROKE DIAGNOSTICS MARKET: BY STAGE, LIFELINE CURVE
FIGURE 39 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET: SNAPSHOT (2020)
FIGURE 40 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET: BY COUNTRY (2020)
FIGURE 41 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 42 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 43 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET: BY SEVERITY (2021-2028)
FIGURE 44 STROKE DIAGNOSTICS MARKET COMPANY SHARE 2020 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.